Onconova Therapeutics plans $20 million at-the-market equity program

Agent Cantor Fitzgerald will sell company’s stock through agreement

By Devika Patel

Knoxville, Tenn., Oct. 8 – Onconova Therapeutics, Inc. negotiated a $20 million at-the-market equity program with Cantor Fitzgerald & Co. on Oct. 8, according to an 8-K filed Wednesday with the Securities and Exchange Commission.

Cantor will be paid a 3% commission.

The clinical-stage biopharmaceutical company is based in Newtown, Pa.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.